First Mercantile Trust’s Adamas Pharmaceuticals ADMS Stock Holding History

First Mercantile Trust’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,678	Closed	-$8K	–	1002
2020 Q1	$8K	Sell	2,678 -749	-22%	-$3.36K	﹤0.01%	832
2019 Q4	$13K	Sell	3,427 -524	-13%	-$2.51K	﹤0.01%	855
2019 Q3	$20K	Sell	3,951 -197	-5%	-$1.22K	﹤0.01%	884
2019 Q2	$26K	Sell	4,148 -687	-14%	-$3.95K	﹤0.01%	802
2019 Q1	$34K	Sell	4,835 -930	-16%	-$8.36K	0.01%	806
2018 Q4	$49K	Buy	5,765 +1,740	+43%	+$22.6K	0.01%	781
2018 Q3	$81K	Buy	4,025 +345	+9%	+$8.1K	0.02%	740
2018 Q2	$95K	Buy	3,680 +175	+5%	+$4.85K	0.02%	725
2018 Q1	$84K	Buy	3,505 +635	+22%	+$20K	0.02%	705
2017 Q4	$97K	Buy	2,870 +320	+13%	+$8.94K	0.02%	720
2017 Q3	$54K	Buy	+2,550	New	+$46.7K	0.01%	769

Other funds holding ADMS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

First Mercantile Trust's ADMS Position: Q2 2020 in Review

First Mercantile Trust sold out of Adamas Pharmaceuticals (ADMS) in Q2 2020, closing a stake of 2,678 shares — an estimated $8K sold.

First Mercantile Trust first reported a position in ADMS in Q3 2017 and held it in 11 quarters. The position peaked at $97K in Q4 2017. 61 funds tracked by Wall St. Rank hold ADMS as of Q2 2020.

First Mercantile Trust reported no remaining Adamas Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
First Mercantile Trust sold 2,678 Adamas Pharmaceuticals shares in Q2 2020, an estimated $8K.
First Mercantile Trust first reported a position in Adamas Pharmaceuticals in Q3 2017 and held it in 11 quarters.
First Mercantile Trust's Adamas Pharmaceuticals position peaked at $97K in Q4 2017.
61 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2020.

Based on First Mercantile Trust's 13F filing for Q2 2020, filed 10 Aug 2020.